Skip to content
HowShorted

AYTU BIOPHARMA, INC short interest in 2023

In 2023, AYTU BIOPHARMA, INC's disclosed short interest ran from 12.31% of shares outstanding on 15 Feb 2023 to 6.76% on 29 Dec 2023, a change of -5.55 percentage points. The year's high was 16.31% on 15 Jun 2023 and its low 6.32% on 29 Sep 2023, averaging 11.32% across 22 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.36 days on 15 Sep 2023. Full history: AYTU BIOPHARMA, INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for AYTU BIOPHARMA, INC in 2023

2023 in figures

Start of year
12.31% (15 Feb 2023)
End of year
6.76% (29 Dec 2023)
Change
-5.55 pp
High
16.31% (15 Jun 2023)
Low
6.32% (29 Sep 2023)
Average
11.32%
Highest days to cover
18.36 (15 Sep 2023)
SEC filings marked
9

Every report in 2023

AYTU BIOPHARMA, INC short interest in 2023
SettlementShort interestDays to coverFilings since previous
15 Feb 202312.31%9.50
28 Feb 202313.82%6.8110-Q filed, results (8-K)
15 Mar 202313.93%8.39
31 Mar 202314.36%10.22
14 Apr 202314.95%14.61
28 Apr 202313.52%3.15
15 May 202315.80%4.5610-Q filed, results (8-K)
31 May 202315.79%10.94
15 Jun 202316.31%8.78
30 Jun 20239.91%4.60
14 Jul 20239.03%14.12
31 Jul 20238.47%11.24
15 Aug 20238.33%10.39
31 Aug 20239.33%13.21
15 Sep 20238.74%18.36
29 Sep 20236.32%1.00results (8-K)
13 Oct 202313.44%6.6310-K filed
31 Oct 202311.44%8.34results (8-K)
15 Nov 202310.83%8.4810-Q filed, results (8-K)
30 Nov 20238.33%16.43
15 Dec 20237.36%14.25
29 Dec 20236.76%11.24

See also: AYTU BIOPHARMA, INC's full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.